GALAGEN INC has a total of 23 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets foods and drinks, pharmaceuticals and biotechnology are CAMPINA NEDERLAND HOLDING BV, TEAGASC AGRIC FOOD DEV AUTHORI and SNOW BRAND MILK PROD CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | United States | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | New Zealand | 2 | |
#6 | Canada | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Foods and drinks | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Dairy products | |
#5 | Food proteins | |
#6 | Special foods | |
#7 | Foods | |
#8 | Climate change adaptation technologies | |
#9 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Bostwick Eileen F | 15 |
#2 | Hoerr Robert A | 7 |
#3 | Gregory Antone G | 7 |
#4 | Ruiz Leonard P | 2 |
#5 | Walsh Richard M | 2 |
#6 | Roush Anne M | 2 |
#7 | Monte Woodrow C | 1 |
Publication | Filing date | Title |
---|---|---|
AU5448801A | Method for microfiltration of milk or colostral whey | |
WO0024266A2 | Soy and immunoglobulin compositions | |
US2002009429A1 | Pharmaceutical composition comprising a selected antigen and candida species antigen and methods | |
US6051270A | Liquid amino acid nutritional composition | |
US5670196A | Method for microfiltration of milk or colostral whey | |
US5858378A | Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen | |
US5707678A | Method for microfiltration of milk or colostral whey | |
NZ291659A | Use in the manufacture of a medicament of an antibody having specific activity against Clostridium difficile, and pharmaceutical compositions comprising Anti-Clostridium difficile bovine immunoglobulin concentrate; for treating diseases associated with Clostridium difficile | |
WO9406474A1 | ANTIBODY TREATMENT OF $i(HELICOBACTER PYLORI) |